Free Trial

Cronos Group (CRON) Competitors

C$3.38
-0.05 (-1.46%)
(As of 06/7/2024 ET)

CRON vs. APHA, BHC, TLRY, THCX, WEED, GUD, ACB, FIRE, CRDL, and EPI

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aphria (APHA), Bausch Health Companies (BHC), Tilray Brands (TLRY), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), Cardiol Therapeutics (CRDL), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Cronos Group vs.

Aphria (TSE:APHA) and Cronos Group (TSE:CRON) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Cronos Group has lower revenue, but higher earnings than Aphria. Cronos Group is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Cronos GroupC$93.03M13.88-C$54.14M-C$0.19-17.79

15.9% of Cronos Group shares are held by institutional investors. 46.5% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Cronos Group Neutral

Aphria has a net margin of 0.00% compared to Aphria's net margin of -61.31%. Cronos Group's return on equity of 0.00% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Cronos Group -61.31%-4.99%-4.02%

Aphria received 312 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 68.04% of users gave Aphria an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

CompanyUnderperformOutperform
AphriaOutperform Votes
381
68.04%
Underperform Votes
179
31.96%
Cronos GroupOutperform Votes
69
50.74%
Underperform Votes
67
49.26%

Cronos Group has a consensus price target of C$3.18, indicating a potential downside of 5.92%.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Aphria beats Cronos Group on 7 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

MetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$1.29BC$1.19BC$5.26BC$5.36B
Dividend YieldN/A3.07%2.77%5.58%
P/E Ratio-17.79502.3693.4523.36
Price / Sales13.888,918.602,437.082,143.06
Price / Cash1.6710.4335.2379.28
Price / Book1.207.674.983.46
Net Income-C$54.14MC$159.95MC$110.69MC$285.54M
7 Day Performance-4.52%-1.09%-1.09%-0.93%
1 Month Performance-13.33%-1.31%-0.96%-0.90%
1 Year Performance50.89%32.45%4.02%26.09%

Cronos Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APHA
Aphria
0 of 5 stars
C$16.55
-5.6%
N/AN/AC$5.24BC$611.06M-8.231,200
BHC
Bausch Health Companies
0.0841 of 5 stars
C$8.60
-0.2%
C$9.00
+4.7%
-9.3%C$3.15BC$8.97B-5.0920,270
TLRY
Tilray Brands
0 of 5 stars
C$2.43
-1.2%
C$2.95
+21.4%
+8.9%C$2.01BC$743.25M-4.051,600
THCX
Hydropothecary
0 of 5 stars
C$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
WEED
Canopy Growth
0.0447 of 5 stars
C$10.53
-3.7%
C$3.78
-64.1%
+946.7%C$790.28MC$362.24M-0.492,700Analyst Forecast
GUD
Knight Therapeutics
1.246 of 5 stars
C$5.73
-2.4%
C$6.75
+17.8%
+18.4%C$580.91MC$332.21M-35.81725News Coverage
Positive News
ACB
Aurora Cannabis
0 of 5 stars
C$8.03
-2.1%
C$2.26
-71.8%
+1,036.2%C$437.96MC$275.88M-0.101,130Upcoming Earnings
FIRE
Supreme Cannabis
0 of 5 stars
N/AN/AN/AC$259.40MC$53.29M-10.97400
CRDL
Cardiol Therapeutics
0 of 5 stars
C$3.59
-5.8%
N/A+245.8%C$247.71MN/A-7.64N/A
EPI
ESSA Pharma
0 of 5 stars
C$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725

Related Companies and Tools

This page (TSE:CRON) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners